SAN CARLOS, Calif., Aug. 29, 2022 /PRNewswire/ — Galaxy Medical today announced that it received the CE Mark for its CENTAURI Pulsed Electric Field (PEF) System and launched its commercial program. The approval allows the company to market the system for the treatment of paroxysmal atrial fibrillation (AF) in the European Union […]
Tag: Galaxy Medical
Galaxy Medical Enrolls first Patients in SPACE-AF study
SAN CARLOS, Calif., Sept. 20, 2021 /PRNewswire/ — Galaxy Medical announced today the initiation of the SPACE-AF study with enrollment of the first two patients at Southlake Regional Health Centre in Newmarket, Canada. In the study, the CENTAURI Pulsed Electric Field (PEF) ablation system will be used to ablate both the pulmonary veins and […]
Galaxy Medical’s ECLIPSE-AF Study 90 Day Remapping Results to be Featured at the 2021 Stanford Biodesign New Arrhythmia Technologies Retreat
SAN CARLOS, Calif., July 22, 2021 /PRNewswire/ — Galaxy Medical announced today that the 90 day remapping results of its ECLIPSE-AF study will be featured at the 2021 Stanford Biodesign New Arrhythmia Technologies Retreat on July 27th. Ante Anić, M.D., Electrophysiology Laboratory Director at University Clinical Hospital in Split, Croatia, and primary investigator of […]
Galaxy Medical and Japan Lifeline Enter Distribution Agreement For Novel Pulsed Electric Field Focal Ablation Catheter
SAN CARLOS, Calif., May 12, 2021 /PRNewswire/ — Galaxy Medical (Galaxy) and Japan Lifeline (JLL) today announced an exclusive distribution agreement for the ALPHA1 ablation catheter in the United States, developed by Japan Lifeline for use with the Galaxy CENTAURI™ Pulsed Electric Field (PEF) System. Under the terms of the agreement, Galaxy will pursue US […]
Galaxy Medical Receives $18 Million from ATP to Advance Development of Its Novel Pulsed Electric Field Ablation Therapy for Cardiac Arrhythmias
–Galaxy’s proprietary CENTAURI™ system on track for EU registration and US pivotal trial start later this year; shows best-in-class potential SAN CARLOS, Calif., March 16, 2021 /PRNewswire/ — ATP, a leader in life science venture capital, announced today $18M in Series A financing for its portfolio company Galaxy Medical, Inc. The funds are being […]
GALAXY Medical CENTAURI PEF System to be Displayed at AF Symposium Recorded Case Presentation
SAN CARLOS, Calif., Jan. 21, 2021 /PRNewswire/ — Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the proprietary CENTAURI™ System will be featured in a recorded case presentation on Sunday January 31st during the upcoming AF Symposium. Ante Anić, EP Lab Director at University Hospital […]
First Patients Treated with Galaxy Medical’s Centauri™ Pulsed Electric Field Cardiac Ablation System
SAN CARLOS, Calif., Oct. 8, 2020 /PRNewswire/ — Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the first patients in the ECLIPSE-AF study were successfully treated with the proprietary Centauri™ System by Dr. Ante Anić in Split, Croatia. This multicenter trial is designed […]



